Alembic Pharma Gets USFDA Approval

  Published 1 year ago

Alembic Pharmaceuticals has received final approval from the USFDA for its Amlodipine and Atorvastatin Tablets USP. This allows the company to market a generic version of the drug in the US market.

  • USFDA approved Alembic's ANDA.
  • Amlodipine & Atorvastatin tablets approved.
  • Expands Alembic's US generic portfolio.

You might like these

UBS Flags Limited Upside for IDFC First Bank

Tech Is a Strategic Differentiator: RBI

SPML Infra Wins ₹385 Cr Water Deal

Chennai Water Project Awarded to SPML-JWIL Consortium

PowerGrid Acquires MPTL for Transmission Project

SBI Seeks Creditor Priority in NHIT

India Stocks Drop Amid Middle East Tensions

News that matters the most ⚡